Gene Therapy Brings Hope for Huntington’s Disease

Quick Smiles:

• Gene therapy AMT-130 slowed Huntington’s progression by 75% over three years.
• Participants receiving the therapy remained more stable, with many showing improvement in daily life and work.
• The one-time treatment is designed to last a lifetime and was generally well-tolerated by patients.

A groundbreaking clinical trial has brought renewed hope to those affected by Huntington’s disease, a condition that until now had no cure or means of slowing its relentless progression.

Researchers found that patients given the gene therapy AMT-130 saw 75% less disease progression compared to those without the treatment, as measured across motor, cognitive, and daily function rating scales.

Lower levels of a protein marker linked to neuron damage were also observed in treated patients, suggesting real protection against disease symptoms over time.

The treatment works by introducing customized DNA to brain cells using a harmless viral vector, providing instructions that help reduce the toxic huntingtin protein that causes degeneration.

Professor Sarah Tabrizi, lead advisor on the trial, shared,

“For patients, AMT-130 has the potential to preserve daily function, keep them in work longer, and meaningfully slow disease progression.”

Those who received the therapy were closely monitored through the complex neurosurgery required to deliver the treatment, and the procedure showed a manageable safety profile.

The success of this trial marks the first significant clinical achievement in altering the course of Huntington’s disease, with participants demonstrating greater stability and, in some cases, a return to work.

Professor Ed Wild, a principal investigator, expressed his enthusiasm,

“This result changes everything.”

UniQure plans to seek accelerated approval from regulatory agencies, hoping to make this treatment available to more families around the world.

This advance signals a new era for genetic medicine, offering genuine hope for patients and their loved ones.

Share this uplifting breakthrough to spread hope to families affected by Huntington’s disease.

Source